Course Content
Multi-System Module — 3rd Year MBBS
AIM STEP 10

Student Memory Support

Organophosphate, Nerve-Gas and Mushroom Poisoning

3rd Year MBBS • Infection and Inflammation • High-yield rapid revision and memory reinforcement

1. High-Yield Flashcards

Tap each question to reveal the answer.

What is the fundamental mechanism of organophosphate toxicity?
Phosphorylation and inhibition of acetylcholinesterase, causing acetylcholine accumulation.
Which three major sites account for organophosphate manifestations?
Muscarinic receptors, nicotinic receptors and the central nervous system.
Which respiratory effects make severe organophosphate poisoning life-threatening?
Bronchorrhea, bronchospasm, respiratory muscle weakness and central respiratory depression.
What is the principal role of atropine in organophosphate poisoning?
Competitive muscarinic receptor blockade, especially reducing bronchial secretions and bronchoconstriction.
Why does atropine not fully correct skeletal muscle weakness?
Skeletal muscle weakness is mainly due to nicotinic neuromuscular effects, not muscarinic receptor stimulation.
Name two cholinesterase-regenerating oximes.
Pralidoxime and obidoxime.
What does “aging” mean in organophosphate poisoning?
A time-dependent stabilization of the phosphorylated acetylcholinesterase complex that reduces oxime reactivation.
Why should an oxime be given early when indicated?
It can reactivate phosphorylated acetylcholinesterase before significant aging occurs.
What is the rationale for pyridostigmine pretreatment before selected nerve-agent exposure?
It reversibly carbamylates part of the acetylcholinesterase pool and temporarily protects it from toxic phosphorylation.
Name four important organophosphate nerve agents.
Tabun, sarin, soman and VX.
Which postmortem respiratory findings may support organophosphate poisoning?
Pulmonary congestion and edema with frothy secretions in the airways.
Why can one fatal dose not be applied to every organophosphate?
Toxicity varies with the compound, formulation, concentration, route and absorbed amount.
How does muscarine produce mushroom toxicity?
By directly stimulating muscarinic acetylcholine receptors.
Which drug is useful for clinically significant muscarinic mushroom poisoning?
Atropine.
Which mushroom poisoning pattern may show apparent improvement before severe hepatic injury?
Amatoxin poisoning.

2. Mnemonics

Mnemonic Title: Cholinergic Respiratory Danger
Mnemonic Word: BBM

Meaning: Bronchorrhea → Bronchospasm → respiratory Muscle weakness.
Mnemonic Title: Major Nerve Agents
Mnemonic Word: TSSV

Meaning: Tabun, Sarin, Soman, VX.
Mnemonic Title: Three Sites of Cholinergic Toxicity
Mnemonic Word: MNC

Meaning: Muscarinic → Nicotinic → Central nervous system effects.

3. Memory Tables

Atropine vs Oxime vs Pyridostigmine

Feature Atropine Oxime Pyridostigmine
Main target Muscarinic receptor Phosphorylated AChE AChE before exposure
Main action Receptor blockade Enzyme reactivation Reversible carbamylation
Key role Controls muscarinic toxicity Given before aging Selected nerve-agent pretreatment

Organophosphate vs Muscarinic Mushroom Poisoning

Feature Organophosphate Muscarinic Mushroom
Mechanism AChE inhibition Direct receptor stimulation
Nicotinic weakness May occur Not explained by muscarine
Atropine Useful Useful for muscarinic syndrome
Oxime target Present before aging No phosphorylated AChE target

4. Rapid Revision Points — Last-Minute Revision

Must Remember:

  • Organophosphates inhibit acetylcholinesterase and increase acetylcholine.
  • Muscarinic excess causes miosis, secretions, bronchospasm and gastrointestinal hyperactivity.
  • Nicotinic toxicity causes fasciculations followed by weakness or paralysis.
  • CNS toxicity may cause confusion, seizures, coma and respiratory depression.
  • Atropine treats dangerous muscarinic manifestations but does not reactivate AChE.
  • Pralidoxime and obidoxime are cholinesterase-regenerating oximes.
  • Aging reduces the ability of oximes to restore phosphorylated acetylcholinesterase.
  • Pyridostigmine is a pretreatment measure for selected anticipated nerve-agent exposure.
  • Pulmonary edema and frothy secretions support organophosphate poisoning but are not specific.
  • Mushroom poisoning is toxin-dependent; not every case is cholinergic.
  • Delayed hepatic deterioration after initial gastrointestinal illness suggests serious amatoxin toxicity.
KMU Exam Trap:

Atropine improves muscarinic effects; oximes act on inhibited acetylcholinesterase. These are different therapeutic targets.

5. Clinical Memory Hooks

Farm worker + miosis + bronchial secretions + fasciculations

Organophosphate-induced cholinergic toxicity
Secretions improve after atropine but weakness persists

Muscarinic effects controlled; nicotinic toxicity remains
Late organophosphate presentation + poor oxime response

Consider aging of phosphorylated acetylcholinesterase
Wild mushrooms + salivation + bradycardia + bronchial secretions

Muscarinic syndrome → atropine
Wild mushrooms + vomiting → apparent improvement → jaundice

Delayed amatoxin-related hepatic injury

6. Starred High-Yield Exam Points

  • ⭐ Organophosphate poisoning = acetylcholinesterase inhibition → acetylcholine accumulation.
  • ⭐ Respiratory failure results from bronchorrhea + bronchospasm + respiratory muscle weakness ± CNS depression.
  • ⭐ Atropine = muscarinic receptor antagonist; improvement in airway secretions is a major therapeutic objective.
  • ⭐ Pralidoxime = cholinesterase reactivator; effectiveness falls after enzyme aging.
  • ⭐ Pyridostigmine pretreatment = reversible AChE carbamylation before selected anticipated nerve-agent exposure.
  • ⭐ Postmortem pulmonary congestion and frothy secretions are supportive but not pathognomonic of organophosphate poisoning.
  • ⭐ Muscarine directly stimulates muscarinic receptors; therefore atropine may help, but an oxime has no phosphorylated AChE target.
Scroll to Top
💬 WhatsApp Support